logo

For the Inventor, By the Inventor

Le Perreux, France

Pierre Henri Derible

This inventor holds 6 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1976-1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Henri Derible. Retrieved from https://idiyas.com/inventor/pierre-henri-derible

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 80(Granted Patents)


Company Filing History:

goldMedal6 out of 854 
 
Roussel Uclaf
 patents

Years Active: 1976-1978

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4108994 - 5-Thiazole-methane-amines, and their use as antilipolytics (1978-08-22),
2. 4018922 - 10-(Piperidin o-alkyl)-phenothiazines (1977-04-19),
3. 3988453 - Novel phenothiazines as neuroleptics (1976-10-26),
4. 3975529 - Diebenzo(B,E)thiepines (1976-08-17),
5. 3950527 - N-[.omega.-(4'-(3'-indolyl)-piperidino)-alkyl]-benzamides (1976-04-13),
6. 3947578 - Omega-[4-(3'-indolyl)-piperidino]-alkyl-arylketones as nevroleptics (1976-03-30),

Title: Pierre Henri Derible: Innovator in Pharmaceutical Chemistry

Introduction

Pierre Henri Derible is a notable inventor based in Le Perreux, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of six patents. His work focuses on developing innovative compounds with therapeutic applications.

Latest Patents

Among his latest patents are the 5-thiazole-methane-amines, which are recognized for their use as antilipolytics. This patent describes a 5-thiazole-methane-amine selected from a specific group of compounds, detailing the structural formula and the various alkyl groups involved. Additionally, he has patented novel 10-(piperidino-alkyl)-phenothiazines, which exhibit neuroleptic, analgesic, spasmolytic, and antihistaminic activities. These compounds also include a comprehensive description of their preparation and the non-toxic, pharmaceutically acceptable acid addition salts.

Career Highlights

Pierre Henri Derible has been associated with Roussel Uclaf, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

He has collaborated with notable colleagues such as Jean-Paul Lavaux and Claude Dumont, enhancing the scope and impact of his research.

Conclusion

Pierre Henri Derible's innovative work in pharmaceutical chemistry has led to the development of important therapeutic compounds. His contributions continue to influence the field and improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…